Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma.
Aoe M, Kanemitsu T, Ohki T, Kishi S, Ogura Y, Takenaka Y, Hashiba T, Ambe H, Furukawa E, Kurata Y, Ichikawa M, Ohara K, Honda T, Furuse S, Saito K, Toda N, Mise N.
Aoe M, et al. Among authors: hashiba t.
Clin Exp Nephrol. 2019 Sep;23(9):1141-1146. doi: 10.1007/s10157-019-01751-4. Epub 2019 Jun 10.
Clin Exp Nephrol. 2019.
PMID: 31183589